Cannabis stocks fall after FDA hearing on CBD finds conflicting views of substance

Cannabis stocks were mostly lower Monday, as investors digested the first reports from Friday’s regulatory hearing on cannabis and its ingredients and the news that Illinois is legalizing weed for adult recreational use.

The FDA has warned companies that because it views CBD as a drug, it cannot be added to food or beverages or marketed as a dietary supplement in interstate commerce. But it has also said that given the strong public interest in CBD as a wellness aid, it will seek to help provide pathways to regulatory approval.

See also: More baby boomers use medical marijuana, but they want their doctors to get wise to the risks and benefits

Even though the News said accept CBD Weeds stocks didn't go any further. $Cron $tlry dead

Typical it will go back up

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

States seeking clarity in booming hemp oil marketCongress threw states a curveball when it legalized CBD. from the first time I tried it, I realized it was more effective than Vicodin for my nerve pain. Lack of preset bias in the situation negates any possibility of placebo effect. It works, I'll attest.
출처: politico - 🏆 381. / 59 더 많은 것을 읽으십시오 »

Stocks Fall as Trump’s Mexico Tariff Threat Rattles MarketsStocks and bond yields fell after President Trump threatened to impose escalating tariffs on Mexico, exacerbating growth concerns in an edgy market.
출처: WSJ - 🏆 98. / 63 더 많은 것을 읽으십시오 »

Oil prices rise on fall in U.S. crude stocks, but trade war worries cap gainsOil prices rose on Thursday after a bigger-than-expected decline in U.S. crude i...
출처: Reuters - 🏆 2. / 97 더 많은 것을 읽으십시오 »